ASSOCIATION BETWEEN OBESITY PHENOTYPES, METABOLIC HEALTH AND NAFLD
Not Applicable
- Conditions
- Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
- Registration Number
- CTRI/2022/11/047422
- Lead Sponsor
- AIIMS New Delhi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Age 18-60 years
Diagnosed with non- alcoholic fatty liver disease
BMI above 18.5 kg/m2
Exclusion Criteria
Known case or recently diagnosed diabetes mellitus
Acute infection and advanced end organ damage
History of pancreatitis
Participants undergone any recent surgery
On any medication within last one month which could potentially influence insulin secretion, insulin sensitivity
Pregnancy and lactation at the time of study.
Chronic heart disease and chronic kidney disease
Acute and chronic hepatitis
Excessive alcohol use ( >20 g a day for women and >30 g for men)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method iver steatosis, liver fibrosis, biochemical and metabolic parameters (lipid profile, liver health markers and anthropometric parameters)Timepoint: One Time (At baseline only)
- Secondary Outcome Measures
Name Time Method ASCVD risk score, FIB-4 Score, NFS Score, Muscle strength, quality of life and sleep qualityTimepoint: One Time (At Baseline only)